Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 2/20 | 0.42 |
| ▸ | PTPN22 | Q9Y2R2 | 1/20 | 0.42 |
| ▸ | DNMT1 | P26358 | 1/20 | 0.42 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.42 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.42 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | THRB | P10828 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | SNCA | P37840 | 2/20 | 0.41 |
| ▸ | RECQL | P46063 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | APP | P05067 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31158554 | 0.81 | CYP1A2 (0.46) | CYP1A2ALDH1A1MCL1PTPN22MAPT | |
| SCHEMBL631770 | 0.81 | CYP1A2 (0.62) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL29587504 | 0.81 | CYP1A2 (0.62) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL10945413 | 0.80 | MCL1 (0.46) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL25215988 | 0.77 | CYP1A2 (0.58) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL30476092 | 0.77 | CYP1A2 (0.58) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL16050549 | 0.77 | CYP1A2 (0.58) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL9018786 | 0.77 | CYP1A2 (0.50) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL30772437 | 0.77 | CYP1A2 (0.56) | CYP1A2MEN1KMT2AALDH1A1MCL1 | |
| SCHEMBL30768157 | 0.77 | CYP1A2 (0.50) | CYP1A2ALDH1A1MCL1PTPN22HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115888396-B | Acid-resistant composite nanofiltration membrane containing water permeation channel and preparation method | 浙大宁波理工学院 | 2023-08-11 | — | — | CN | claimed |
| CN-115888396-A | Acid-resistant composite nanofiltration membrane containing water permeation channel and preparation method | 浙大宁波理工学院 | 2023-04-04 | — | — | CN | claimed |
| CN-113736104-A | Super-hydrophobic metal organic framework material and preparation method and application thereof | 暨南大学 | 2021-12-03 | — | — | CN | claimed |
| EP-3031856-B1 | CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOFa | AGC INC (JP) | 2019-07-10 | — | — | EP | claimed |
| US-10066077-B2 | Crosslinkable fluorinated elastomer composition and crosslinked product thereof | ASAHI GLASS COMPANY, LIMITED (JP) | 2018-09-04 | — | — | US | claimed |
| EP-3031856-A1 | FLUORINE-CONTAINING CROSSLINKABLE ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOF | Asahi Glass Company, Limited (JP) | 2016-06-15 | — | — | EP | claimed |
| US-20160137809-A1 | CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOF | ASAHI GLASS COMPANY, LIMITED (JP) | 2016-05-19 | — | — | US | claimed |
| US-8519080-B2 | Crosslinkable prepolymer, its production process and its uses | ASAHI GLASS COMPANY, LIMITED (JP) | 2013-08-27 | — | — | US | claimed |
| CN-101454375-B | Crosslinkable prepolymer, process for production thereof, and use thereof | ASAHI GLASS CO LTD | 2012-06-06 | — | — | CN | claimed |
| US-8168742-B2 | Crosslinkable fluorinated aromatic prepolymer and its uses | ASAHI GLASS COMPANY, LIMITED (JP) | 2012-05-01 | — | — | US | claimed |
| CN-115888396-B | Acid-resistant composite nanofiltration membrane containing water permeation channel and preparation method | 浙大宁波理工学院 | 2023-08-11 | — | — | CN | disclosed |
| CN-115888396-A | Acid-resistant composite nanofiltration membrane containing water permeation channel and preparation method | 浙大宁波理工学院 | 2023-04-04 | — | — | CN | disclosed |
| CN-113736104-A | Super-hydrophobic metal organic framework material and preparation method and application thereof | 暨南大学 | 2021-12-03 | — | — | CN | disclosed |
| EP-3031856-B1 | CROSSLINKABLE FLUORINATED ELASTOMER COMPOSITION AND CROSSLINKED PRODUCT THEREOFa | AGC INC (JP) | 2019-07-10 | — | — | EP | disclosed |
| US-10066077-B2 | Crosslinkable fluorinated elastomer composition and crosslinked product thereof | ASAHI GLASS COMPANY, LIMITED (JP) | 2018-09-04 | — | — | US | disclosed |
| US-20040147710-A1 | Improved heat resistance and low relative permittivity; insulating films for electronic devices/multilayerd wiring boards | ASAHI GLASS COMPANY LIMITED (JP) | 2004-07-29 | — | — | US | disclosed |
| US-20040116361-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-06-17 | — | — | US | disclosed |
| US-20040106686-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2004-06-03 | — | — | US | disclosed |
| US-20030229032-A1 | Antihelminthic anthraquinones and method of use thereof | BOARD OF TRUSTEES OF MICHIGAN STATE UNIVERSITY | 2003-12-11 | — | — | US | disclosed |
| WO-2003089577-A2 | ANTIHELMINTHIC ANTHRAQUINONES AND METHOD OF USE THEREOF | MICHIGAN STATE UNIVERSITY (US) | 2003-10-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229032-A1 | Antihelminthic anthraquinones and method of use thereof | HRH2, HRH3, HRH1 | CYP1A2 171/4885MEN1 3190/4885KMT2A 703/4885 |
| US-20040106686-A1 | Antihelminthic anthraquinones and method of use thereof | HRH2, HRH3, HRH1 | CYP1A2 171/4885MEN1 3190/4885KMT2A 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.